Listed

Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2026

Filed with the SEC on Aug 28, 2026 and accepted by EDGAR at Aug 28, 2026, 09:14 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Shares outstandingAt period end2026-06-30217,508,862 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001437749-26-029135. Last ingested by Listed: Nov 12, 2026, 17:12 ET. Listed shows no prices and gives no investment advice.